Sironax
Cambridge, United States· Est.
Sironax is a biotechnology company discovering and developing therapies targeting cellular senescence to treat age-related diseases such as fibrosis, neurodegeneration, and ophthalmology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $200M
About
Sironax is a biotechnology company discovering and developing therapies targeting cellular senescence to treat age-related diseases such as fibrosis, neurodegeneration, and ophthalmology.
Regenerative MedicineOphthalmologyNeuroscience
Funding History
1Total raised:$200M
Series B$200M